The emerging therapy of the medication represents a major development in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide185727.timeblog.net/77924822/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment